Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

HI-TECH PHARMACAL CO. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of Hi-Tech Pharmacal Co. in Connection With the Sale of the Company -- HITK

NEW YORK, Sept. 4, 2013 (GLOBE NEWSWIRE) -- Levi & Korsinsky notifies investors of Hi-Tech Pharmacal Co. ("Hi-Tech" or the "Company") (Nasdaq:HITK) of claims of breaches of fiduciary duty and other violations of state law against the board of directors of the Company in connection with the sale of the Company to Akorn, Inc. (Nasdaq:AKRX). A complaint was filed in Delaware state court.

Click here to learn more about the case http://zlk.9nl.com/hi-tech-pharmacal-hitk/, or call: 877-363-5972. There is no cost or obligation to you.

Under the terms of the transaction, Hi-Tech shareholders will receive $43.50 for each share of Hi-Tech stock they own. The transaction has a total approximate value of $640 million. The claims concern whether the Hi-Tech Board of Directors breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether Akorn, Inc. is underpaying for Hi-Tech shares.

If you own Hi-Tech common stock and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/hi-tech-pharmacal-hitk/.

Levi & Korsinsky is a national firm with offices in New York, New Jersey and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major securities lawsuits and have successfully recovered multimillion-dollar damages awards on behalf of investors. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT: Levi & Korsinsky, LLP
         Joseph Levi, Esq.
         Eduard Korsinsky, Esq.
         30 Broad Street - 24th Floor
         New York, NY 10004
         Tel: (212) 363-7500
         Toll Free:  (877) 363-5972
         Fax: (212) 363-7171
         www.zlk.com